PharmaShots Weekly Snapshot (April 15-19, 2019)
Published: April 18, 2019 | Tags: Almac Diagnostic, Collaborates, Queen’s University, Personalized Chemotherapy, Esophageal Cancer
Published: April 17, 2019 | Tags: NICE, Publishes, Final Recommendation, Almirall, Ilumetri, tildrakizumab, Treat, Moderate-To-Severe, Plaque Psoriasis, Adults
Published: April 18, 2019 | Tags: Mylan, TB Alliance, Collaborates, Commercialize, Pretomanid, Two, Combination Regimens, Tuberculosis
Published: April 18, 2019 | Tags: AbbVie, Skyrizi, risankizumab, Receives, Health Canada, Approval, Moderate, Severe, Plaque Psoriasis
5.Pfizer & Eli Lilly Report Results of Tanezumab in Long-Term P-III Study for Osteoarthritis
Published: April 18, 2019 | Tags: Pfizer, Eli Lilly, Report, Results, Tanezumab, Long-Term, P-III, Study, Osteoarthritis, OA
6.World Health Organization (WHO) Reports 10 Guidelines on Digital Health Interventions
Published: April 17, 2019 | Tags: World Health Organization, WHO, Reports, 10, Guidelines, Digital Health Interventions
Published: April 17, 2019 | Tags: OncoSec, Signs, Research Agreement, Duke University School of Medicine, Evaluate, Combination, TAVO, HER2-Plasmid Vaccine
Published: April 17, 2019 | Tags: Medtronic, Reports, Results, VenaSeal Closure System, VeClose Extension Study, Chronic Venous Diseases
Published: April 17, 2019 | Tags: CASI Pharmaceutical, Signs, Exclusive, Worldwide, License, Agreement, Black Belt, TSK011010, Program
Published: April 17, 2019 | Tags: Boehringer Ingelheim, Collaborates, PureTech, Develop, Immuno-Oncology, Product, Immune Modulation
Published: April 16, 2019 | Tags: FDA, Orders, Stop, Commercialization, Surgical Mesh, Pelvic Collapse, US
Published: April 16, 2019 | Tags: Gilead, Collaborates, Insitro, Discover, Develop, Novel Therapies, Nonalcoholic Steatohepatitis, NASH, 3yrs
Published: April 16, 2019 | Tags: Thermo Fisher, Collaborates, NX Prenatal, Develop, Proteomics Assays, Adverse Pregnancy Outcomes
Published: April 16, 2019 | Tags: Novartis, Reports, Results, P-III, STR1VE Study, Zolgensma, onasemnogene abeparvovec-xioi, Spinal Muscular Atrophy, SMA, Type 1
Published: April 16, 2019 | Tags: Tessa, Collaborates, Merck, Evaluate, Combination Therapy, Metastatic, Recurrent, Cervical Cancer
Published: April 15, 2019 | Tags: Alnylam, Initiates, P-III, ILLUMINATE-B, Lumasiran, Primary Hyperoxaluria Type 1, PH1, Pediatric Patients
Published: April 15, 2019 | Tags: Janssen, Expands, Clinical Development, Guselkumab, Tremfya(R), Familial Adenomatous Polyposis, FAP
18.Eagle Restructured its Licensing Agreement with Teva for Bendeka (bendamustine hydrochloride)
Published: April 15, 2019 | Tags: Eagle, Restructured, Licensing Agreement, Teva, Bendeka, bendamustine hydrochloride
Published: April 15, 2019 | Tags: Castle Creek, Collaborates, Fibrocell, Develop, Commercialize, FCX-007, Gene Therapy, Recessive Dystrophic Epidermolysis Bullosa, RDEB
20.Novartis Reports FDA’s Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD
Published: April 15, 2019 | Tags: Novartis, Reports, FDA, Acceptance, BLA, Brolucizumab, RTH258, Treat, Wet AMD
21.Santhera to Present Result of DELOS & SYROS Study at the 2019 MDA Clinical and Scientific Conference
Published: April 15, 2019 | Tags: Santhera; Present; Result; DELOS; SYROS; Study; 2019; Clinical; Scientific; Conference
22.Dr. Reddy’s to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US
Published: April 13, 2019 | Tags: Dr. Reddy’s, Acquire, 42, Abbreviated New Drug Applications, ANDA, US
Published: April 12, 2019 | Tags: Tracon, Terminate, P-III, TAPPAS Trial, TRC105, carotuximab, Votrient, pazopanib, Advanced, Metastatic Angiosarcoma
24.Alnylam Reports Results of Givosiran in P-III ENVISION Study to Treat Acute Hepatic Porphyria
Published: April 12, 2019 | Tags: Alnylam, Reports, Results, Givosiran, P-III, ENVISION, Study, Treat Acute Hepatic Porphyria